Why I’d sell Fevertree Drinks plc to buy this stock

Roland Head looks at the latest figures from 10-bagger Fevertree Drinks plc (LON:FEVR).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Investors who took shares in the 2014 flotation of Fevertree Drinks (LSE: FEVR) have seen the value of their stock rise by 1,023% in less than three years. I suspect this company has created a number of new millionaires among UK investors.

The secret to the stock’s rocketing growth is that sales and profits have repeatedly beaten forecasts. This is still happening. Tuesday’s interim results revealed that sales have risen by 77% to £71.9m during the first half of the year. Adjusted earnings per share doubled to 16.7p, up from 8.1p for the first half of 2016.

The board now expects full-year results to be “materially ahead of its expectations”. The shares have risen by 9% to a new high of almost 1,900p. So why would I sell some of this stock today?

The numbers tell a story

This is clearly a great business, with an attractive product, high profit margins and a strong balance sheet. Today’s results make it clear that the group still has significant growth potential by expanding overseas, and moving into the market for dark spirits mixers, like cola.

However, it’s worth noting that Fevertree has accounted for 99% of the value growth in the entire UK mixer retail market over the last 12 months. It now holds a 30% market share. Without stealing huge slices of business from incumbents such as Coca-Cola and Schweppes, I find it hard to see how much higher these figures can rise.

After today’s news, I estimate that the stock trades on a 2017 forecast P/E of about 55. The risk for investors is that profits could double again and the shares would still look expensive. Founder Charles Rolls recently sold a quarter of his shares, netting £73m. I’d consider doing the same.

This is what I’d do with the cash

I don’t think the market for soft drinks and mixers is going to disappear in my lifetime. Government plans for a sugar tax have been effectively handled by drinks firms, who don’t seem to expect any impact on sales.

If you’re keen on this sector, what I’d do would be to recycle some cash from Fever-Tree into another high quality company that’s more mature, and offers a decent income. My choice would be A.G. Barr (LSE: BAG), which owns brands including Irn Bru, Rockstar, Snapple and Strathmore. The company also produces drinks for other companies.

These brands trade at a lower point in the market than Fever-Tree’s premium mixers. But Barr’s business has a very long pedigree. Robert Barr started selling soft drinks in 1875. The group recently held its 113th annual general meeting.

Although the shares aren’t cheap on a forecast P/E of 20, they offer a yield of 2.5% that’s covered twice by earnings. Dividend growth has averaged 9.1% per year since 2012. The group’s operating margin has averaged an impressive 15% over the same period.

Investors in Barr won’t double their money next year. But this is a stock I’d buy on the dips, and would be happy to hold through a recession. In my view, buying Barr would be a good way to convert some Fever-Tree profits into a long-term income.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any shares mentioned. The Motley Fool UK has recommended AG Barr. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Passive income text with pin graph chart on business table
Investing Articles

Yields of up to 7%! I’d consider boosting my income with these FTSE dividend stocks

The London market has some decent-looking dividend stocks right now, and I’m tempted by these two for growing income streams.

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

I’d put £20K in an ISA now to target a £1,900 monthly second income in future!

Christopher Ruane shares why he thinks a long-term approach to investing and careful selection of shares could help him build…

Read more »

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »